Our Purpose
Neuro Post is a hub for people who care about where brain science is actually headed. We gather and translate the latest clinical studies in neurology into clear, usable insights so patients and families can stay ahead of what’s coming next. Our goal is simple: make the science that shapes lives understandable, trustworthy, and part of everyday conversation.
Our Commitment
We are committed to write for the people. Every study we highlight is read, contextualized, and checked against the broader clinical landscape. We surface both breakthroughs and limitations, giving our readers enough signal to ask better questions, challenge assumptions, and make more informed decisions.
Vision
We imagine a world where the latest neuroclinical evidence is not locked in journals, but alive in discussion rooms, clinics, classrooms, and patient communities. Neuro Post aims to be the place where that conversation starts — a shared space where research meets real life, and where staying informed feels less like work and more like joining the conversation at the watercooler.
Our Team
Sanne Zwikker
Co-Founder
Sanne Zwikker is a goal‑driven biologist with a primary interest in Gene Therapy, Stem Cell Therapy, mRNA Therapy, and CAR T‑Cell Therapy, focused on accelerating the transition from traditional allopathic medicine to Advanced Therapy Medicinal Products (ATMPs). She is completing her BS in Biological Sciences on the pre‑med track at the University of Rochester, where she has published in the Journal of Undergraduate Research on Neuronal Ceroid Lipofuscinoses (NCL) preclinical data and co‑authored a whitepaper on immunotherapy for classical Hodgkin’s Lymphoma. Her research experience spans Western blotting, gel electrophoresis, enzymatic assays, and developmental analysis through animal dissection, including identifying embryonic abnormalities in a cow fetus. Mentored by Erin Fredericksen, Project Manager at Kapadi and former Clinical Research Manager at Sloan Kettering Memorial Cancer Center and Yale University, Sanne is driven by the conviction that major breakthroughs in ATMPs are imminent and is committed to contributing at the forefront of these advancements.
Elles Zwikker
Co-Founder
Elles Zwikker is the co-founder of Neuro Post. She is an aspiring biochemist, currently studying at Columbia Edge, and frequently voices discussion about lymphoma, Parkinson’s disease, and their impact on patient quality of life. She’s a passionate voice in the advancement of cell and gene therapies, and her contributions to the field reflect both scientific depth and compassionate care, including her leadership in an animal hospice supporting end-of-life care for terminally ill patients.